Project Start
2000-09-22
Project End
2005-09-21
Budget Start
2000-09-22
Budget End
2002-09-21
Support Year
Fiscal Year
2000
Total Cost
$6,151,669
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Sullivan, Keith M; Goldmuntz, Ellen A; Keyes-Elstein, Lynette et al. (2018) Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. N Engl J Med 378:35-47
Keever-Taylor, Carolyn A; Heimfeld, Shelly; Steinmiller, Kaitlyn C et al. (2017) Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases. Biol Blood Marrow Transplant 23:1463-1472
Sullivan, Keith M; Shah, Ankoor; Sarantopoulos, Stefanie et al. (2016) Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement. Arthritis Rheumatol 68:2361-71
Hung, Emily W; Mayes, Maureen D; Sharif, Roozbeh et al. (2013) Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial. J Rheumatol 40:455-60
Bowen, J D; Kraft, G H; Wundes, A et al. (2012) Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results. Bone Marrow Transplant 47:946-51
Hosing, Chitra; Nash, Richard; McSweeney, Peter et al. (2011) Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. Biol Blood Marrow Transplant 17:674-81
Craciunescu, Oana I; Steffey, Beverly A; Kelsey, Chris R et al. (2011) Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial. Int J Radiat Oncol Biol Phys 79:1248-55
Stefely, Jonathan A; Palchaudhuri, Rahul; Miller, Patricia A et al. (2010) N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines. J Med Chem 53:3389-95
Sullivan, Keith M; Muraro, Paolo; Tyndall, Alan (2010) Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States. Biol Blood Marrow Transplant 16:S48-56
Wang, J; Nash, R A; Chu, B et al. (2009) Improvements in digital vasculature observed using micro magnetic resonance angiography after high-dose immunosuppression for severe systemic sclerosis. Bone Marrow Transplant 44:387-9

Showing the most recent 10 out of 15 publications